Gemini Therapeutics, Inc. ($GMTX)
Filing Information
| Accession Number | 0001193125-26-055646 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
5,531
Total Value
$347,678.66
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Feb 17, 2026 | Sale | 5,531 | $62.86 | $347,678.66 | 80,998 | Direct | โ | View Details |